Tumori Journal

Papers
(The H4-Index of Tumori Journal is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Exploring new frontiers: Outcomes and feasibility of a third radiotherapy course in recurrent prostate cancer57
A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone approval43
Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer17
Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide13
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis12
Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study11
Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age10
Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort9
Chemo-surgical approach in vulvar leiomyosarcoma: A case report8
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach8
Optimising combination therapy for paediatric, adolescent and young adult patients with non-rhabdomyosarcoma soft tissue sarcomas: The OCTOPUS platform trial8
Blooming in the rain8
0.069855928421021